The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rhokiinsa

200 microgram(s)/millilitre Eye drops, solution

Aerie Pharmaceuticals Ireland LimitedEU/1/19/1400/001

Main Information

Trade NameRhokiinsa
Active SubstancesNETARSUDIL MESILATE
NETARSUDIL
Strength200 microgram(s)/millilitre
Dosage FormEye drops, solution
Licence HolderAerie Pharmaceuticals Ireland Limited
Licence NumberEU/1/19/1400/001

Group Information

ATC CodeS01EX05 netarsudil

Status

Authorised/WithdrawnAuthorised
Licence Issued19/11/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back